A detailed history of Benin Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Benin Management Corp holds 1,175 shares of ABBV stock, worth $235,552. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,175
Previous 1,295 9.27%
Holding current value
$235,552
Previous $222,000 4.5%
% of portfolio
0.07%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$163.84 - $199.33 $19,660 - $23,919
-120 Reduced 9.27%
1,175 $232,000
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $27,397 - $31,994
-177 Reduced 12.02%
1,295 $222,000
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $5,753 - $6,555
36 Added 2.51%
1,472 $268,000
Q4 2023

Jan 25, 2024

BUY
$137.6 - $154.97 $197,593 - $222,536
1,436 New
1,436 $222,000
Q1 2021

Apr 27, 2021

SELL
$102.3 - $112.62 $20,460 - $22,524
-200 Reduced 3.31%
5,850 $633,000
Q3 2020

Oct 22, 2020

SELL
$85.91 - $100.83 $42,955 - $50,415
-500 Reduced 7.63%
6,050 $530,000
Q2 2020

Jul 22, 2020

SELL
$73.37 - $98.18 $7,337 - $9,818
-100 Reduced 1.5%
6,550 $643,000
Q1 2020

Apr 20, 2020

BUY
$64.5 - $97.79 $6,450 - $9,779
100 Added 1.53%
6,650 $507,000
Q4 2019

Jan 23, 2020

SELL
$72.13 - $90.25 $79,343 - $99,275
-1,100 Reduced 14.38%
6,550 $580,000
Q3 2019

Oct 22, 2019

BUY
$62.98 - $75.72 $9,447 - $11,358
150 Added 2.0%
7,650 $579,000
Q2 2019

Jul 31, 2019

BUY
$65.7 - $83.98 $98,550 - $125,970
1,500 Added 25.0%
7,500 $545,000
Q4 2018

Jan 22, 2019

BUY
$77.85 - $96.01 $11,677 - $14,401
150 Added 2.56%
6,000 $553,000
Q1 2018

Apr 24, 2018

BUY
$92.01 - $123.21 $46,005 - $61,605
500 Added 9.35%
5,850 $554,000
Q4 2017

Jan 18, 2018

SELL
$89.56 - $98.21 $89,560 - $98,210
-1,000 Reduced 15.75%
5,350 $517,000
Q3 2017

Oct 13, 2017

BUY
$69.85 - $89.22 $443,547 - $566,547
6,350
6,350 $564,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Benin Management Corp Portfolio

Follow Benin Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benin Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Benin Management Corp with notifications on news.